Changing Lives Through Research

Saligman-Funded Projects Yield Insights for
Liver Transplant, Lung Cancer Patient Care
Over the past five years, the Saligman Family Surgery Pilot Grant Program has supported 21 novel research ideas
within the Department of Surgery, sparking innovation for our faculty and trainees alike. These projects explore a
range of topics related to improving the quality and safety of surgical care. What follows are highlights of two studies
that have demonstrated success and long-term potential for continued research to improve patient care.

Primary Non-Function
Following Liver Transplant:
How Do We Define High Risk
Retransplant Candidates?

Evaluating Variations in Lung
Cancer Surgical Outcomes
Along Referral Pathways
Principal Investigator:
Tyler S. Grenda, MD, MS

Principal Investigator:
Adam S. Bodzin, MD

Lung cancer screening has gained momentum
with healthcare payers, including the Centers
for Medicare and Medicaid Services (CMS),
based on mortality benefits demonstrated in
screening trials. These benefits are predicated
on early detection in at-risk populations, as
well as subsequent treatment of those
diagnosed with lung cancers.

Although deceased donor liver transplant
success rates are excellent, transplant
physicians still face the most feared
complication: primary non-function (PNF)
of liver allografts.
This pilot has been using the Scientific Registry
of Transplant Recipients (SRTR) database to
evaluate the number of patients who experience PNF following a liver transplant.
Dr. Bodzin, along with resident Peter Altshuler, MD, and other members of the team,
are identifying the proportion of patients with PNF who undergo retransplantation
and analyzing their survival rates. After retransplantation, patients have considerably
lower survival rates compared to those for whom the primary transplant is a success.

“Surgical resection is the standard of care for
early-stage disease,” explains Dr. Grenda. “Yet there is significant variation in mortality
across nationally representative cohorts of patients.”
With the help of the Saligman Grant funding, Dr. Grenda and his team purchased
individual state inpatient databases from both the Healthcare Cost and Utilization
Project (HCUP) and the Pennsylvania Healthcare Cost Containment Council. They
are using these databases to further evaluate the relationship between services used
and quality of patient care.

In the past year, this team has performed extensive analysis of more than 3,000
patients who suffered PNF. They used that analysis to create a Recipient PNF Futility
Score, which they presented at the Philadelphia Academy of Surgery, where the
paper earned second place out of 68 submissions.

“More specifically, we are evaluating the quality and efficiency of care from the initial
diagnosis or staging evaluation to postoperative care,” Dr. Grenda says. “We’re
working to determine if certain provider ‘networks’ or referral patterns simply provide
higher-quality care across the entire continuum for lung cancer.”

Their analysis also identified an unintended subpopulation of patients with PNF who
are relisted for transplant but improve on their own and have long-term survival
without retransplant.

This team has already generated preliminary data to motivate future studies and
serve as pilot data for additional work aimed at better understanding quality and
efficiency in lung cancer care.

“We want to understand which pretransplant characteristics might predict this ability
to experience PNF and improve without retransplant,” explains Dr. Bodzin. “This will
be another important patient population that we will define by a risk model,
ultimately guiding physician management of this dreaded morbidity.”

“We hope our efforts will help in identifying factors underlying variation in lung
cancer outcomes and opportunities for quality improvement across the spectrum of
care,” he concludes.
To learn more about supporting Jefferson’s surgical research efforts,
please contact Kelly Austin at 215-955-6383 or kelly.austin@jefferson.edu.

On the Job

Sean Maher, MBA

Sean Maher joined the Department
of Surgery in March 2021 as Senior
Business Manager, bringing a decade of
experience in healthcare management.
As an undergraduate at the Pennsylvania
State University, he earned a degree
in Health Policy Administration. After
graduation, he spent more than five
years at the University of Pennsylvania
Health System, starting in the
Department of Neurology.
After moving to the Temple Health
System, he discovered that his true
passion is in the financial – not
operational – side of healthcare

management. While at Temple, he
earned an MBA from Gwynedd Mercy
University and advanced to become
Senior Financial Analyst for projections,
handling budgets for the entire health
system.
As the Department of Surgery’s Senior
Business Manager, Maher is applying
his skills in financial management and
analysis. In addition to having overall
responsibility for the Department’s
budget, Maher is working to
streamline the collection, analysis
and dissemination of financial data
to clinicians within the Department.
He is building a financial model to

help physicians to better understand
and continually improve their own
performance data.
“I’m most excited about getting this
statistical information to the physicians
on a monthly basis,” he says. “Once
everything is automated, they’ll be
able to drill down to see the financial
information associated with the
procedures they are performing.”
Maher, who grew up in Northeast
Philadelphia, met his wife in Sea Isle
City (his favorite vacation). They now
live in Upper Dublin with their daughter,
Quinn, who turns two in August.
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